Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients-Reference-Cited by-同舟云学术

Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients

Published:2016-02 Issue:2 Volume:6 Page:e397-e397
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Kortuem K M,Braggio E,Bruins L,Barrio S,Shi C S,Zhu Y X,Tibes R,Viswanatha D,Votruba P,Ahmann G,Fonseca R,Jedlowski P,Schlam I,Kumar S,Bergsagel P L,Stewart A K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj20161.pdf

Reference24 articles.

1. Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 2014; 5: 2997.

2. Walker BA, Boyle EM, Wardell CP, Murison A, Begum DB, Dahir NM et al. Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma. J Clin Oncol 2015; 33: 3911–3920.

3. Lonial S, Yellapantula VD, Liang W, Kurdoglu A, Aldrich J, Legendre CM et al. Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression 2014, ASH Meeting abstracts, 06 December 2014, p 722.

4. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell 2014; 25: 91–101.

5. Brioli A, Melchor L, Cavo M, Morgan GJ . The impact of intra-clonal heterogeneity on the treatment of multiple myeloma. Br J Haematol 2014; 165: 441–454.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies;The Journal of Molecular Diagnostics;2024-07

2. Aiming for the cure in myeloma: Putting our best foot forward;Blood Reviews;2023-11

3. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial;Cancers;2022-10-21

4. Perspectives on the Risk-Stratified Treatment of Multiple Myeloma;Blood Cancer Discovery;2022-06-02

5. Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma;Leukemia;2022-01-13